leadf
logo-loader
viewMarrone Bio Innovations

Marrone Bio announces retirement of president and CFO James Boyd

A national search process for a new CFO is underway and Boyd will continue in both posts during the transition

Marrone Bio
CEO Kevin Helash said Boyd 'helped guide the company through its successful transition as a market leader in the agricultural biologicals space'

Marrone Bio Innovations Inc (NASDAQ:MBII) announced Tuesday that president and chief financial officer James Boyd is retiring.

A national search process for a new CFO is underway, and Boyd will continue in both posts during the search process, the company said in a statement.

“Jim has been a key member of the senior management team and a highly-regarded leader for the company over the last seven years,” said CEO Kevin Helash. 

READ: Marrone Bio and Rizobacter to distribute foliar fertilizer and plant health technology in Argentina, Uruguay, Paraguay and Bolivia

“He has helped guide the company through its successful transition as a market leader in the agricultural biologicals space. On behalf of myself, the board of directors and the entire team at Marrone Bio Innovations, we want to thank Jim for his numerous contributions to the strength of the company and wish him the very best in his retirement,” Helash added.

The CEO said the company is “looking for an exceptional individual to help lead the company during its next phase of accelerated growth while ensuring we are brilliant at the basics that drive operational and financial excellence.”

He added: “We have a solid financial team in place and expect the new CFO to be able to make a rapid transition and add immediate value.”

Boyd said he is “proud to have helped build the company into a world-class organization” with an unmatched product portfolio in sustainable biological products.  

“Given our recent revenue growth and margin expansion, I am confident the company is poised to deliver meaningful shareholder value. I look forward to working with our finance team as we make this transition and ensure the company’s continuing success,” Boyd said.

Based in Davis, California, Marrone Bio holds more than 400 issued and pending patents and has brought six US Environmental Protection Agency-registered biological product lines and one biostimulant to market. 

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: Marrone Bio Innovations

Price: 1.16 USD

NASDAQ:MBII
Market: NASDAQ
Market Cap: $176.87 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Marrone Bio Innovations announces alliance with South American company...

Marrone Bio Innovations (NASDAQ: MBII) Chief Commerical Officer Kevin Hammill joined Steve Darling from Proactive to share news the company has taken a step forward on global expansion by announcing an alliance with the South American company Rizobacter to distribute novel plant health and crop...

on 09/25/2020

2 min read